0001601485-18-000001.txt : 20180717 0001601485-18-000001.hdr.sgml : 20180717 20180717161239 ACCESSION NUMBER: 0001601485-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180717 DATE AS OF CHANGE: 20180717 EFFECTIVENESS DATE: 20180717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-317099 FILM NUMBER: 18956636 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (516) 326-1200 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 D 1 primary_doc.xml X0708 D LIVE 0001601485 Angion Biomedica Corp. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY NEW YORK 11553 (516) 326-1200 DELAWARE None None Corporation true Itzhak D. Goldberg 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chairman and Secretary Jay Venkatesan 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Executive Officer Director Chief Executive Officer Michael Yamin 51 Charles Lindbergh Boulevard Uniondale NY NEW YORK 11553 Director Biotechnology Decline to Disclose 06b false 2017-01-11 false true true true false 50063 T.R. Winston & Company, LLC 10571 None None 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 CA CALIFORNIA NY NEW YORK false 5438891 5438891 0 No such securities remain outstanding and the offering is terminated. false 18 363222 0 The placement agent was also issued 446 Series B warrants and reimbursement of $25,000 in expenses. 0 false Angion Biomedica Corp. /s/ Jay Venkatesan Jay Venkatesan Chief Executive Officer 2018-07-17